Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Minority Interest (2022 - 2025)

Historic Minority Interest for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$10.0 million.

  • PAVmed's Minority Interest changed N/A to -$10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.0 million, marking a year-over-year change of. This contributed to the annual value of -$4.5 million for FY2024, which is 11522.15% down from last year.
  • Per PAVmed's latest filing, its Minority Interest stood at -$10.0 million for Q3 2025.
  • Over the past 5 years, PAVmed's Minority Interest peaked at $55.3 million during Q2 2024, and registered a low of -$10.0 million during Q3 2025.
  • Moreover, its 4-year median value for Minority Interest was $20.1 million (2022), whereas its average is $19.5 million.
  • Per our database at Business Quant, PAVmed's Minority Interest skyrocketed by 8024.57% in 2024 and then crashed by 11694.48% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Minority Interest stood at $20.6 million in 2022, then soared by 44.62% to $29.8 million in 2023, then plummeted by 115.22% to -$4.5 million in 2024, then plummeted by 120.21% to -$10.0 million in 2025.
  • Its Minority Interest stands at -$10.0 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$6.1 million for Q1 2025.